PB Ratio of Venmax Drugs & Pharmaceuticals Ltd
Venmax Drugs & Pharmaceuticals Ltd
NSE: VENMAXDRUGS
PB Ratio
Key Highlights
- The latest PB Ratio of Venmax Drugs & Pharmaceuticals Ltd is 1.4.
- The PB ratio of the Venmax Drugs & Pharmaceuticals Ltd is below 1.5 which indicates that the stock is fairly valued The P/B Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from -22.6 on March 2025 to -22.6 on March 2025 . This represents a CAGR of 0.00% over 1 years .
Historical P/B Ratio of Venmax Drugs & Pharmaceuticals Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Venmax Drugs & Pharmaceuticals Ltd
Company Fundamentals for Venmax Drugs & Pharmaceuticals Ltd
Market Cap
20 Cr
EPS
0.2
P/E Ratio (TTM)
83.6
P/B Ratio (TTM)
1.4
Day’s High
19.2
Day’s Low
17.01
DTE
0.0
ROE
1.8
52 Week High
36.96
52 Week Low
15.56
ROCE
1.9
Market Price of Venmax Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 28 Jul 2026 | 17.56 |
| 27 Jul 2026 | 16.12 |
| 24 Jul 2026 | 15.94 |
| 23 Jul 2026 | 16.9 |
| 22 Jul 2026 | 17.06 |
| 21 Jul 2026 | 16.65 |
| 20 Jul 2026 | 16.74 |
| 17 Jul 2026 | 16.5 |
| 16 Jul 2026 | 16.7 |
| 15 Jul 2026 | 16.32 |
SWOT Analysis Of Venmax Drugs & Pharmaceuticals Ltd
BlinkX Score for Venmax Drugs & Pharmaceuticals Ltd
Asset Value vs Market Value of Venmax Drugs & Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap |
|---|
| Venmax Drugs & Pharmaceuticals Ltd | 1.44 | 20.34 |
| Sun Pharmaceutical Industries Ltd | 93.8 | 474397 |
| Divis Laboratories Ltd | 661.2 | 196990 |
| Torrent Pharmaceuticals Ltd | 221.8 | 186354 |
| Cipla Ltd | 431.8 | 116705 |
| Company | |
|---|---|
| Venmax Drugs & Pharmaceuticals Ltd | 1.44 |
| Sun Pharmaceutical Industries Ltd | 93.8 |
| Divis Laboratories Ltd | 661.2 |
| Torrent Pharmaceuticals Ltd | 221.8 |
| Cipla Ltd | 431.8 |
PB Ratio of Venmax Drugs & Pharmaceuticals Ltd Explained
₹20.34
Market cap
₹12
Book Value per Share
1.4X
PB Ratio
Historical Market Cap of Venmax Drugs & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Venmax Drugs & Pharmaceuticals Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Venmax Drugs & Pharmaceuticals Ltd News Hub
Venmax Drugs & Pharmaceuticals to conduct board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 Au
Read more
16 Aug 24
Venmax Drugs & Pharmaceuticals standalone net profit declines 50.00% in the June 2024 quarter
Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended J
Read more
13 Aug 24
Venmax Drugs & Pharmaceuticals to hold board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 Au
Read more
03 Aug 24
Venmax Drugs & Pharmaceuticals to hold AGM
Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company w
Read more
27 Aug 24
